Replies to post #181661 on Biotech Values

[acgood]

jq1234, the side effects you pointed out illustrate very well why I would not want to take LLY's new insulin over a lifetime. I also found it odd that LLY did not report the range of HbA1c below 7 that was achieved.

Yes, and what about T1D patients who are already have well-controlled A1C? Not sure why they would switch...